Advertisement

Topics

Corey McPherson Nash Company Profile

12:50 EST 21st November 2017 | BioPortfolio


News Articles [180 Associated News Articles listed on BioPortfolio]

US FDA rejects Pfizer's Epogen biosimilar citing McPherson site warning

Concerns about Pfizer’s fill/finish plant in McPherson, Kansas have prompted the US FDA to reject the firm’s biosimilar version of Amgen’s anaemia drug Epogen.

Corey Feldman Defends Needing $10 Million to Reveal Names of Alleged Hollywood Pedophiles in Feature Film

Corey Feldman believes the sexual harassment allegations rippling through Hollywood are “just the tip of the iceberg

#jobs #lifescience Chemist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chemist .KS-Mcpherson, Job Title: Analytical Chemist I Location: McPherson, K...

Corey Feldman Begs for Peers Who Witnessed Pedophilia in Hollywood to Come Forward

Corey Feldman is speaking out again about the alleged abuse he suffered as a child actor — abuses he claims are part of a larger problem of pedophilia in Hollywood

Behind The NASH Leaders, Pursuers Already Anticipating Second-Wave Improvements

Privately held Cirius and NGM and big pharma Bristol-Myers Squibb are in Phase II for NASH with programs also working...   

GENFIT – The NASH Education ProgramTM annonce le lancement de la première Journée Internationale d’Information sur la NASH, le 12 juin 2018

GENFIT — Thursday, July 13th 2017 at 5:19pm UTC GENFIT – The NASH Education ProgramTM annonce le lancement de la première Journée Internationale d’Information sur la NASH, le 12 ju...

Corey Haim's Mother Says Charlie Sheen Did Not Abuse Her Late Son But Claims Another Man Did

Corey Haim‘s mother is speaking out about a report that Charlie Sheen allegedly raped her late son when he was 13-years-old

Boehringer Ingelheim Partners with Target PharmaSolutions to Progress NASH Research

CHAPEL HILL, N.C., Oct. 19, 2017 /PRNewswire/ — TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Boehringer Ingelheim International GmbH has entered ...

PubMed Articles [114 Associated PubMed Articles listed on BioPortfolio]

Nation-wide trends in non-alcoholic steatohepatitis (NASH) in patients with and without diabetes between 2004-05 and 2014-15 in England.

There are no national studies evaluating the epidemiology of non-alcoholic steatohepatitis (NASH) in England. NASH is becoming an increasingly important health issue given the inexorable rise in obesi...

A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Non-alcoholic Steatohepatitis (NASH).

Nonalcoholic steatohepatitis (NASH) is the most prevalent cause of chronic liver disease in the Western world. However, an optimum therapy for NASH is yet to be established mandating more in-depth inv...

Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.

Nonalcoholic fatty liver disease (NAFLD) is a major public health concern in western societies. Nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, is characterized by hepatic steatosi...

The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement.

Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and overweight. It has a broad spectrum of clinical and histological presentations, such as steatosis, inflammation (kno...

Bile acid alterations are associated with insulin resistance, but not with NASH in obese subjects.

Bile acids (BA) are signalling molecules controlling energy homeostasis which can be both toxic and protective for the liver. BA alterations have been reported in obesity, insulin resistance (IR) and ...

Clinical Trials [116 Associated Clinical Trials listed on BioPortfolio]

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

CP-945598 is a potent and selective Cannabinoid-1 (CB1) receptor antagonist currently being developed for the treatment of obesity. CP-945598 is also being considered as a potential treat...

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

The primary objective of this study is the proof of mechanism and support of dose finding, together with the safety evaluation in patients with clinical evidence of NASH. To gain further ...

A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NAFLD or NASH in usual clinical practice. TARGET-NASH will create a research registry of patients wit...

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis (BEAT-NASH)

Obesity is an epidemic in the US. With progression of obesity, Nonalcoholic steatohepatitis (NASH) has been a growing public health issue. Presently there is no cure for NASH.Prevention of...

Companies [25 Associated Companies listed on BioPortfolio]

Corey McPherson Nash

Nash Finch Company

Patricia Nash

The quintessential embodiment of style, form and function, Patricia Nash Designs creates handbags and accessories that are made of beautiful, vegetable tanned Italian leather. The...

North American Specialty Hospital

Headquartered in Denver, NASH is a US majority-owned and managed enterprise. Incorporating US physicians in its service delivery, NASH is designed to provide pre-operative and pos...

HARVEY NASH GROUP

Harvey Nash was founded in London in 1988. David Higgins, the current Executive Vice Chairman, was one of the original founders and still has a sizeable financial stake in the company. Early on, the m...

More Information about "Corey McPherson Nash" on BioPortfolio

We have published hundreds of Corey McPherson Nash news stories on BioPortfolio along with dozens of Corey McPherson Nash Clinical Trials and PubMed Articles about Corey McPherson Nash for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Corey McPherson Nash Companies in our database. You can also find out about relevant Corey McPherson Nash Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record